Plan sponsors are facing a chronic disease “tsunami” that is leading to higher benefits and drug plan spend and increasing disability claims. But the three root causes of this growing problem — undiagnosed health issues, the availability of primary and preventative health care and challenges navigating the health-care system — are issues plan sponsors are […]
While a transplant can be life-altering for a patient as a permanent cure for their underlying condition, it can also profoundly affect their immune system, according to Dr. Matthew Cheng, assistant professor in transplant infectious diseases and medical mycology at McGill University, speaking during a panel discussion at Benefits Canada’s Face to Face Drug Plan […]
The most powerful and durable investment themes are those where ingenuity sparks innovation to address imbalances in the world, said David Docherty, investment director for thematics at Schroders, when speaking at the Canadian Investment Review’s Investment Innovation Conference in November. He pointed to imbalance between population and resources as an example, and themes related to […]